ASSESSMENT OF CLINICAL PHARMACIST ROLE IN DRUG SAFETY IN A TERTIARY CARE HOSPITAL: AN OBSERVATIONAL STUDY

Background: Drug Safety is a crucial part of healthcare delivery., as medication errors and inappropriate prescribing significantly affect patient outcomes. Drug-related problems (DRPs), including drug interactions, dosing errors contraindications, and untreated conditions, are common in hospital settings, especially people with polypharmacy. several comorbidities. Clinical Pharmacists are essential function within recognizing, averting, and resolving these medication-related issues, thereby enhancing patient safety. Objectives: To assess clinical pharmacists' contributions to enhancing medication safety among hospitalized patients. Methods: A hospital based Over the course of six months, an observational research was performed in a tertiary care facility. A sum of 256 patients of all age groups receiving drug therapy (inpatients and outpatients) were added in accordance with defined Inclusion and exclusion criteria. Data were collected. using structured case collection forms. Results: Drug-related problems were identified across multiple departments, with the highest prevalence observed in General Medicine and departments managing complex and polypharmacy cases. Drug interactions were the most frequently reported DRP, particularly in Neurology/Neurosurgery (60%), Cardiology (54.5%), Urology (57.1%), and Chest & TB/Respiratory Medicine (66.7%). Dose-related errors, duplication errors, contraindications, omission errors, and untreated conditions were also observed. Patient-related compliance problems were minimal, with under-use (0.8%), over-use (0.4%), and erratic use (0.4%) reported in very few cases. Laboratory monitoring was required in 17.2% of patients. Clinical pharmacist interventions contributed to the identification and resolution of medication errors, optimization of drug therapy, and improved patient adherence. Conclusion: The study demonstrates that drug-related problems are prevalent in hospital settings, particularly in departments handling complex therapeutic regimens. Clinical pharmacist involvement significantly improves drug safety by identifying and resolving medication errors, optimizing therapy, and enhancing interdisciplinary collaboration. Integrating clinical pharmacists into the healthcare team is essential for reducing medication errors, improving patient outcomes, and strengthening the medication safety system. Clinical Pharmacist; Drug Safety; Drug-Related Problems (DRPs); Medication Errors; Drug Interactions; Polypharmacy; Patient Safety; Medication Monitoring; Hospital-Based Study.

Authors

Publication Details

Journal
International Journal of Drug Delivery Technology
Published
2026-11-16
DOI
https://doi.org/10.25258/ijddt.16.79s.10
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ASSESSMENT OF CLINICAL PHARMACIST ROLE IN DRUG SAFETY IN A TERTIARY CARE HOSPITAL: AN OBSERVATIONAL STUDY

Mohammad Mohasin Pasha, Deepika Kola, SHAIK YASMEEN, GADAGONI SAI TEJA GOUD et al.
2 links
International Journal of Drug Delivery Technology
Pharmaceutical Practices and Patient Outcomes
article

ASSESSMENT OF CLINICAL PHARMACIST ROLE IN DRUG SAFETY IN A TERTIARY CARE HOSPITAL: AN OBSERVATIONAL STUDY

Mohammad Mohasin Pasha, Deepika Kola, SHAIK YASMEEN, GADAGONI SAI TEJA GOUD, MUSOJU SOWMYA
article en

Abstract

Background: Drug Safety is a crucial part of healthcare delivery., as medication errors and inappropriate prescribing significantly affect patient outcomes. Drug-related problems (DRPs), including drug interactions, dosing errors contraindications, and untreated conditions, are common in hospital settings, especially people with polypharmacy. several comorbidities. Clinical Pharmacists are essential function within recognizing, averting, and resolving these medication-related issues, thereby enhancing patient safety. Objectives: To assess clinical pharmacists' contributions to enhancing medication safety among hospitalized patients. Methods: A hospital based Over the course of six months, an observational research was performed in a tertiary care facility. A sum of 256 patients of all age groups receiving drug therapy (inpatients and outpatients) were added in accordance with defined Inclusion and exclusion criteria. Data were collected. using structured case collection forms. Results: Drug-related problems were identified across multiple departments, with the highest prevalence observed in General Medicine and departments managing complex and polypharmacy cases. Drug interactions were the most frequently reported DRP, particularly in Neurology/Neurosurgery (60%), Cardiology (54.5%), Urology (57.1%), and Chest & TB/Respiratory Medicine (66.7%). Dose-related errors, duplication errors, contraindications, omission errors, and untreated conditions were also observed. Patient-related compliance problems were minimal, with under-use (0.8%), over-use (0.4%), and erratic use (0.4%) reported in very few cases. Laboratory monitoring was required in 17.2% of patients. Clinical pharmacist interventions contributed to the identification and resolution of medication errors, optimization of drug therapy, and improved patient adherence. Conclusion: The study demonstrates that drug-related problems are prevalent in hospital settings, particularly in departments handling complex therapeutic regimens. Clinical pharmacist involvement significantly improves drug safety by identifying and resolving medication errors, optimizing therapy, and enhancing interdisciplinary collaboration. Integrating clinical pharmacists into the healthcare team is essential for reducing medication errors, improving patient outcomes, and strengthening the medication safety system. Clinical Pharmacist; Drug Safety; Drug-Related Problems (DRPs); Medication Errors; Drug Interactions; Polypharmacy; Patient Safety; Medication Monitoring; Hospital-Based Study.

International Journal of Drug Delivery TechnologyVol. 16(80s)
Good health and well-being
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon